- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01980368
Tai Chi Easy in Treating Cancer Survivors With Peripheral Sensory Neuropathy
Pilot Study of Effects of Tai Chi Easy on Cancer Survivors Experiencing Neuropathy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES:
I. Examine effects of Tai Chi Easy (TCEasy) exercise intervention on peripheral sensory neuropathy of cancer survivors who have chemotherapy compared with an educational control (EC) intervention.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I (TAI CHI EASY): Patients attend Tai Chi Easy class for 60 minutes once a week for 6 weeks. Patients also receive a DVD and exercise manual of Tai Chi Easy exercises and are encouraged to practice at home for 30 minutes most days per week for 6 weeks.
GROUP II (EDUCATIONAL CONTROL): Patients receive readings each week and attend a book club to discuss the readings for 60 minutes once a week for 6 weeks.
After completion of study, patients are followed up at 2 months.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1 month - 5 years following completion of cytotoxic chemotherapy treatment for any cancer, and are experiencing neuropathy
- Self-report of >= 4 on the Peripheral Neuropathy Question
Exclusion Criteria:
- Recurrence of cancer or other active cancer
- Severe cachexia, dizziness, bone pain, or severe nausea (as judged by the investigator)
- Uncontrolled diabetes, untreated hypothyroidism
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group I (Tai Chi Easy)
Patients attend Tai Chi Easy class for 60 minutes once a week for 6 weeks.
Patients also receive a DVD and exercise manual of Tai Chi Easy exercises and are encouraged to practice at home for 30 minutes most days per week for 6 weeks.
|
Ancillary studies
Receive Tai Chi Easy class, DVD, and exercise manual
|
Active Comparator: Group II (educational control)
Patients receive readings each week and attend a book club to discuss the readings for 60 minutes once a week for 6 weeks.
|
Ancillary studies
Receive readings and attend book club
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in peripheral sensory neuropathy, assessed by Peripheral Neuropathy Question, European Organization for Research and Treatment of Cancer (EORTC)-30, EORTC-Chemotherapy-induced peripheral neuropathy-20, and the modified Total Neuropathy Score
Time Frame: Baseline up to 2 months
|
Will be assessed with a simple t-test of mTNS means.
Additional analyses of factors assessed will similarly be conducted (and overall analysis of variance when combining outcome variable assessment at the three time points, and models of factor contribution with logistic regression if appropriate).
|
Baseline up to 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in anxiety assessed by POMS Total Mood Disturbance dimensions (tension-anxiety)
Time Frame: Baseline up to 2 months
|
Baseline up to 2 months
|
|
Changes in body mass index assessed by weight and height
Time Frame: Baseline up to 2 months
|
Will be measured directly using standardized protocols with medical-quality calibrated balance scales.
|
Baseline up to 2 months
|
Changes in cognitive performance assessed by digit span and letter-number sequencing
Time Frame: Baseline up to 2 months
|
Baseline up to 2 months
|
|
Changes in depression assessed by Program Operations Manual System (POMS) Total Mood Disturbance dimensions (depression-dejection)
Time Frame: Baseline up to 2 months
|
Baseline up to 2 months
|
|
Changes in fatigue assessed by Fatigue Symptom Inventory
Time Frame: Baseline up to 2 months
|
Baseline up to 2 months
|
|
Changes in pain assessed by Medical Outcomes Study-Short Form 36
Time Frame: Baseline up to 2 months
|
Baseline up to 2 months
|
|
Changes in sleep quality assessed by Pittsburgh Sleep Quality Index and actigraph
Time Frame: Baseline up to 2 months
|
Baseline up to 2 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Donald Northfelt, Mayo Clinic
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-007483 (Other Identifier: Mayo Clinic in Arizona)
- P30CA015083 (U.S. NIH Grant/Contract)
- NCI-2016-01373 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Survivor
-
University of New MexicoNew Mexico State University; University of New Mexico Cancer CenterCompleted
-
Ohio State University Comprehensive Cancer CenterCompletedCancer SurvivorUnited States
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Canadian Breast Cancer FoundationCompletedBreast Cancer Survivor | Pediatric Cancer SurvivorCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Oncology Nursing Society; Villanova UniversityCompletedChildhood Cancer SurvivorUnited States
-
Turku University HospitalLounais-Suomen SyöpäyhdistysNot yet recruiting
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnCancer SurvivorUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Auburn UniversityCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedCancer SurvivorUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); National Institute of Mental Health (NIMH)CompletedCancer SurvivorUnited States
Clinical Trials on Questionnaire Administration
-
Fondazione Don Carlo Gnocchi OnlusUnknown
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedHealth Status UnknownUnited States
-
Istanbul Aydın UniversityCompleted
-
Centre Oscar LambretCentre Hospitalier Universitaire de BesanconTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingLi-Fraumeni SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm | Caregiver | Advanced Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
Istituto Auxologico ItalianoCompletedObesity | Eating DisordersItaly
-
Vanderbilt-Ingram Cancer CenterTerminatedMalignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Federico II UniversityUnknownSleep Disorder | Renal Transplant | Hypertension; NephropathyItaly